Answers are grounded in this paper and cite their sources.
Background: The Patient-Reported Outcomes in Actinic Keratosis (PROAK) study evaluated patient- and clinician-reported outcomes (PRO; ClinRO) during 24 weeks of follow-up among adult patients with actinic keratosis (AK) on the face or scalp who were administered tirbanibulin 1% ointment in real-world community practices in the United States.
No takes yet. Share an insight, caveat, or question.
Schlesinger et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: